- Home
- NLY vs FMS Comparison
NLY vs FMS Comparison
Compare NLY & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NLY
- FMS
- Stock Information
- Founded
- NLY 1996
- FMS 1996
- Country
- NLY United States
- FMS Germany
- Employees
- NLY N/A
- FMS N/A
- Industry
- NLY Real Estate Investment Trusts
- FMS Misc Health and Biotechnology Services
- Sector
- NLY Real Estate
- FMS Health Care
- Exchange
- NLY Nasdaq
- FMS Nasdaq
- Market Cap
- NLY 12.6B
- FMS 13.8B
- IPO Year
- NLY 1997
- FMS 1996
- Fundamental
- Price
- NLY $19.23
- FMS $28.36
- Analyst Decision
- NLY Buy
- FMS Hold
- Analyst Count
- NLY 11
- FMS 1
- Target Price
- NLY $21.11
- FMS $25.00
- AVG Volume (30 Days)
- NLY 7.4M
- FMS 470.3K
- Earning Date
- NLY 04-30-2025
- FMS 05-06-2025
- Dividend Yield
- NLY 14.56%
- FMS 2.78%
- EPS Growth
- NLY N/A
- FMS 27.83
- EPS
- NLY 0.93
- FMS 2.28
- Revenue
- NLY $933,585,000.00
- FMS $21,068,786,202.00
- Revenue This Year
- NLY $332.50
- FMS $3.18
- Revenue Next Year
- NLY $0.63
- FMS $3.62
- P/E Ratio
- NLY $20.57
- FMS $24.92
- Revenue Growth
- NLY N/A
- FMS 0.10
- 52 Week Low
- NLY $16.60
- FMS $17.93
- 52 Week High
- NLY $22.11
- FMS $25.96
- Technical
- Relative Strength Index (RSI)
- NLY 50.00
- FMS 72.95
- Support Level
- NLY $18.93
- FMS $25.55
- Resistance Level
- NLY $19.39
- FMS $28.59
- Average True Range (ATR)
- NLY 0.38
- FMS 0.40
- MACD
- NLY 0.12
- FMS 0.42
- Stochastic Oscillator
- NLY 62.34
- FMS 95.46
About NLY Annaly Capital Management Inc.
Annaly Capital Management Inc is an American mortgage real estate investment trust. Its business objective is to generate net income for distribution to its stockholders and optimize its returns through prudent management of its diversified investment strategies. The company's reportable operating segments are; the Agency segment, which invests in Agency mortgage-backed securities collateralized by residential mortgages; the Residential Credit segment, which invests in non-Agency residential whole loans and securitized products within the residential and commercial markets; the Mortgage Servicing Rights segment; and Corporate & Other. Maximum revenue for the company is generated from its Agency segment.
About FMS Fresenius Medical Care AG
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three quarters of sales while the balance is generated from medical technology products that enable dialysis treatments.